NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Oxford Blood Group
    • Case Studies
    • PPIE Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Modernising Medical Microbiology and Big Infection Diagnostics > Large-scale COVID-19 infection and antibody test study launched

Large-scale COVID-19 infection and antibody test study launched

23 April 2020 · Listed under COVID-19, Modernising Medical Microbiology and Big Infection Diagnostics, Translational Data Science

Some 20,000 households across England are being contacted to take part in the first wave of a major new government study to track the COVID-19 coronavirus in the general population.

Prof Sarah Walker

The study will help improve understanding around the current rate of infection and how many people are likely to have developed antibodies to the virus. Chief Investigator for the study is Sarah Walker, Professor of Medical Statistics and Epidemiology at the University of Oxford and the NIHR Oxford Biomedical Research Centre’s Co-theme Lead for Antimicrobial Resistance and Modernising Microbiology.

Participants in the study will form a representative sample of the entire UK population by age and geography. The results will help scientists and the government in the ongoing response to the coronavirus outbreak, with initial findings expected to be available in early May.

Led by the Department for Health and Social Care (DHSC) and the Office for National Statistics (ONS), the study draws on the world-leading scientific expertise of Prof Walker and her team, backed by the testing capabilities of data science company IQVIA UK and the National Biosample Centre in Milton Keynes. 

The flagship study forms part of Pillar 4 of the government’s COVID-19 testing strategy, to conduct UK-wide surveillance testing to learn more about the spread of the disease and help inform the development of new tests and treatments. It will add to the population data already being collected through the national surveillance programme operated by Public Health England, which has been enhanced since the end of February.

Prof Walker said: “This is one of the largest and most important studies under way into the COVID-19 virus and will transform our understanding of the infection. The University of Oxford is delighted to be the study sponsor.”

“In this study we want to work out how many people of different ages across the UK have Covid-19 now and how many have had Covid-19 in the past. We do this by testing for the virus in the nose and throat of people and by measuring levels of antibody in the blood.

“We also want to find out how many people have Covid-19 over time – either with symptoms or without knowing they have the infection because they don’t have any symptoms. We want to do this in a group of people that reflects the population of the UK, so a range of ages and places where people live.”

Health Secretary Matt Hancock said: “Understanding more about the rate of COVID-19 infection in the general population, and the longer-term prevalence of antibodies, is a vital part of our ongoing response to this virus.

“This survey will help to track the current extent of transmission and infection in the UK, while also answering crucial questions about immunity as we continue to build up our understanding of this new virus.

“Together, these results will help us better understand the spread of the virus to date, predict the future trajectory and inform future action we take, including crucially the development of ground-breaking new tests and treatments.”

Participants will provide samples taken from self-administered nose and throat swabs and answer a few short questions during a home visit by a trained health worker. The swab tests will show whether or not participants currently have the virus. They will be asked to take further tests every week for the first five weeks, then every month for 12 months.

In total, 25,000 people will take part in the pilot phase of the survey, with plans to extend it to up to around 300,000 over the next 12 months.

Adults from around 1,000 households will also provide a blood sample taken by a trained nurse, phlebotomist or healthcare assistant. These tests will help determine what proportion of the population has developed antibodies to COVID-19. Participants will be asked to give further samples monthly for the next 12 months.  

Swabs will be taken from all participating households, whether their members are reporting symptoms or not. Blood will not be taken in any households where someone has symptoms of COVID-19 or is currently self-isolating or shielding.

The trained study health workers will use all the recommended precautions to protect themselves and everyone in the household from getting the virus. Swab test results will be communicated back to participants by their GPs and confidentiality will be protected throughout the process. 

← BRC funds three further COVID-19 studies
Oxford COVID-19 vaccine begins human trial stage →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre